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Abstract
Background: Asthma is a common complex condition with clear racial and ethnic differences in both prevalence and
severity. Asthma consultation rates, mortality, and severe symptoms are greatly increased in African descent populations of
developed countries. African ancestry has been associated with asthma, total serum IgE and lower pulmonary function in
African-admixed populations. To replicate previous findings, here we aimed to examine whether African ancestry was
associated with asthma susceptibility in African Americans. In addition, we examined for the first time whether African
ancestry was associated with asthma exacerbations.
Methodology/Principal Findings: After filtering for self-reported ancestry and genotype data quality, samples from 1,117
self-reported African-American individuals from New York and Baltimore (394 cases, 481 controls), and Chicago (321 cases
followed for asthma exacerbations) were analyzed. Genetic ancestry was estimated based on ancestry informative markers
(AIMs) selected for being highly divergent among European and West African populations (95 AIMs for New York and
Baltimore, and 66 independent AIMs for Chicago). Among case-control samples, the mean African ancestry was significantly
higher in asthmatics than in non-asthmatics (82.0614.0% vs. 77.8618.1%, mean difference 4.2% [95% confidence interval
(CI):2.0–6.4], p,0.0001). This association remained significant after adjusting for potential confounders (odds ratio: 4.55, 95%
CI: 1.69–12.29, p=0.003). African ancestry failed to show an association with asthma exacerbations (p=0.965) using a model
based on longitudinal data of the number of exacerbations followed over 1.5 years.
Conclusions/Significance: These data replicate previous findings indicating that African ancestry constitutes a risk factor for
asthma and suggest that elevated asthma rates in African Americans can be partially attributed to African genetic ancestry.
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Introduction
Asthma is a complex chronic inflammatory condition affected
by both genetic and environmental factors [1] that, despite having
a low associated mortality (1%), remains a major health risk
affecting about 7% (range of 1–18%) of the human population [2].
Among the U.S. population, African descent groups experience
higher rates of asthma prevalence and mortality than European
Americans [3,4], suggesting that the disease might be more
aggressive in African descent groups [4]. In support of this
hypothesis, African Americans with asthma tend to show lower
baseline pulmonary function indices [4], greater severity of airway
obstruction, increased acuity, and increased hospital admissions
compared to European counterparts, despite presenting similar
clinical features [5]. Although environmental or cultural differ-
ences and socioeconomic factors are thought to be the major
determinants of such divergences, accumulated evidence from
genetic linkage and association studies suggest that genetic
differences among populations may also be involved in ethnic
disparities in asthma incidence and severity.
Asthma and atopy-related phenotypes have been linked to
incompletely overlapping chromosome regions across the different
U.S. ethnic groups [6,7]. Similarly, genome-wide association
studies (GWAS) in asthma in European descent populations have
highlighted genes and regions widely associated across indepen-
dent European samples, such as GSDMB-ORMDL3 [8], PDE4D
[9], and CRB1-DENND1B [10], that have been modestly
replicated or did not show association in African Americans [11]
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2or Hispanics [12] despite sufficient sample sizes [13]. Conversely,
associations with asthma in the PYHIN1 gene were found to be
specific to African descent individuals from North America [13],
and the only GWAS in asthma conducted to date in Hispanics
revealed novel asthma associations in the TLE4-CHCHD9
intergenic region with protective alleles likely to be originated in
the Native American ancestral population [12]. Although this lack
of replicability of regions/genes from linkage analysis and GWAS
efforts may reflect inadequate coverage of genetic variation in non-
European descent populations in commercial genotyping arrays,
these results may also suggest that lack of generalizability of these
findings across populations due to allele differences, gene-gene and
gene-environmental interactions important for the disease. This
scenario would be favored if multiple rare variants, which are
more likely to be population specific, are involved in disease
causality [14]. This rationale is congruent with current concepts of
asthma pathogenesis derived from candidate gene association
studies [15], suggesting that no single gene can be considered an
asthma susceptibility gene across all populations. Alternatively,
ethnic differences for disease incidence and severity may be also
explained by the frequency differences for risk alleles underlying
the disease [13,16], which might be substantially increased in
specific population groups compared to others [12,17].
African Americans are a recently admixed population showing,
on average, ,80% admixture with African populations, the
remaining being of European ancestry [18]. However, at individual
level, African Americans show considerable variation in such
proportions [19]. In this situation, for a given disease demonstrating
ethnic disparities in predisposition, it is expected that genomic
segments that originated from the ancestral ethnic group with the
higher risk will be enriched with risk alleles [20]. Thus, a larger
proportion ofancestryfromtheancestralpopulationwiththehigher
disease risk is expected in affected compared to unaffected
individuals. With this premise, previous studies in African-admixed
populations have demonstrated that the African genetic ancestry
was both associated with risk of asthma and total serum IgE in a
Caribbean population [21], and with lower pulmonary function
measures in asthmatic and non-asthmatic African Americans
[22,23], the latter suggesting that current diagnosis of severe asthma
can be improved if genetic ancestry information is considered for
risk assessment [23]. None of these studies have investigated if
African ancestry was associated with asthma severity or exacerba-
tions. Furthermore, no study has examined if African ancestry was
associated with asthma risk in populations other than the
Caribbean. Given the importance of replicating the observations
from association studies of genetics with disease [24], here we aimed
to determine if the African genetic ancestry was also associated with
asthma risk in an independent sample of African Americans. In
addition, we examined for the first time whether African ancestry
was associated with asthma exacerbations.
Methods
Ethics statement
The study was approved by the Institutional Review Boards of
Johns Hopkins Bloomberg School of Public Health, Children’s
Memorial Hospital, John H. Stroger Hospital of Cook County,
and Northwestern University Feinberg School of Medicine. All
subjects gave written consent.
Samples from Reducing Emergency Asthma Care in
Harlem (REACH)/ Baltimore Asthma Severity Study (BASS)
A total of 875 African Americans, including 394 asthmatic cases
and 481 non-asthmatic control subjects, donated a blood sample
for genetic analysis in the context of the Reducing Emergency
Asthma Care in Harlem (REACH) study and Baltimore Asthma
Severity Study (BASS) [25]. These samples have been recently
utilized for genetic association studies [11,26]. Briefly, the
participants in both studies responded to a standardized,
interviewer-administered questionnaire that included a modified
version of the 1987 American Thoracic Society Division of Lung
Disease Epidemiology Questionnaire to collect information on
demographics, clinical severity, as well as psychosocial determi-
nants of asthma control.
REACH study population consisted of unrelated adults residing
in Harlem, a predominantly African American community in New
York City, recruited after a visit to the Harlem Hospital
Emergency Department (ED) [25]. Briefly, adult English-speaking
residents of Central Harlem or West Harlem who visited the
Harlem Hospital Center ED for asthma exacerbations or for non-
asthmatic and non-allergic conditions between March 1997 and
February 1998 were eligible to participate in the study.
Participants were asked to visit an outpatient chest clinic with a
scheduled interview approximately 3 weeks following the ED visit.
Asthma diagnosis was confirmed or discarded based on an
evaluation by a trained pulmonary physician and a structured
comprehensive asthma questionnaire was administered in a face-
to-face interview lasting approximately 1.5 h. Control participants
were recruited in the ED at the time of visits for non-respiratory,
non-allergic conditions. Control participants reported no history of
asthma, allergies or lung disease. Recorded variables included
sociodemographic information, self-reported ethnicity, respiratory
symptoms (self-reported), family history of asthma, allergy and
lung diseases, smoking exposure, alcohol consumption and
physical activity, height and weight, utilization of health-care,
psychological measures, general health status, use of asthma
medication, asthma severity according to the sleep-awakening
symptoms in the National Asthma Education and Prevention
Program (NAEPP) [27], spirometric values, total IgE and the
atopic status. Note, however, that pulmonary function data were
obtained only for a small proportion of the asthmatic participants
because they were enrolled within less than 6 weeks of requiring
emergency care. Atopy was defined by the evidence of allergic
sensitization to known allergens, reflected by either a positive skin
prick test (SPT; with a wheal diameter 3 mm greater than the
saline control) or positive specific IgE (with serum levels
.0.35 kUI/mL) to one or more of the following allergens: dust
mite, epithelium (cat and dog), ragweed, Timothy grass, Alternaria
spp and cockroach. The study group was a predominantly low-
income population [25].
BASS study population is a community-based convenience
sample of unrelated African American adults with residence in
Baltimore City, including physician-diagnosed asthmatic cases and
control subjects recruited between October 2002 and July 2006.
Participants were asked to complete a face-to-face questionnaire.
Asthma was defined as a positive response to the question ‘‘Have
you ever been told by a physician that you have asthma?‘‘ and to a
similar question for use of medication for asthma symptoms.
Subjects were considered controls based on the negative response
to these questions, and a negative spirometry with bronchodilators.
Recorded variables for all participants included sociodemographic
information, self-reported ethnicity, asthma symptoms (self-
reported), family history of asthma, allergy and lung diseases,
health-care utilization, smoking exposure, alcohol and drug
consumption, psychological measures, and medical history of
hypertension, diabetes, depression, heart disease, pneumonia, and
kidney diseases. In addition, a spirometric evaluation with
bronchodilators was completed for both cases and controls.
African Ancestry and Asthma Risk
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Equity (CHIRAH) cohort study
The CHIRAH cohort is a community-based longitudinal cohort
study of urban children and adults with persistent asthma from
Chicago. The cohort was established by a broad community-based
screening for households with unrelated persons aged 8–40 with
asthma [28,29]. All eligible study participants were required to
have a history of physician-diagnosed persistent, symptomatic
asthma, defined in this screening process as requiring at least 8
weeks of asthma medication over the previous 12 months.
Recorded information included age, gender, self-reported ances-
try, household members with asthma, age at diagnosis, education
and income, tobacco exposure, among others [28]. Longitudinal
data on asthma exacerbations were also collected at the first visit
and at 6 additional follow-up contacts every 3 months. Spirometric
assessment was performed only at the first visit following the
guidelines of the American Thoracic Society [30]. For the
purposes of this study, all 321 asthma patients self reported as
African American who provided informed consent to participate
in a nested study of genetic risk factors in asthma were included.
Genotyping
Genotyping was conducted using the iPLEX Gold
TM Platform
following the manufacturer’s protocol (Sequenom, San Diego,
CA). Briefly, iPLEX
TM assays were scanned by MALDI-TOF
mass spectrometry and individual SNP genotype calls were
automatically generated using Sequenom TYPER 3.4
TM software.
REACH and BASS samples were genotyped for 96 ancestry
informative markers (AIMs) selected for being highly divergent
(average allele frequency difference, d, .0.6) among European,
African and Native American/Asian populations [26,31,32].
Table S1 shows a list of the AIMs and frequency divergences
among 60 Europeans and 131 West Africans that were used to
derive the ancestry estimates of this study [26]. Kosoy et al [33]
showed that subsets of this panel as small as 24 AIMs were useful
for ascertaining the origin of subjects from different continents
among American populations.
CHIRAH samples were genotyped for an independent panel of
66 highly divergent AIMs among Europeans and Africans (d$0.3),
which are listed in Table S2 along with frequencies in samples
from these populations [34,35].
Duplicate samples and negative controls were included across
the plates to ensure genotyping quality. Genotyping was blinded to
the case and control status. The majority of automatic genotype
calls (84.5%) had .85% confidence quality scores. All had
completion rates above 90% except for rs6894171 in REACH and
BASS, for which missing data exceeded 50%. For this reason, this
AIM was not considered for further analyses. Samples with
genotype calls below 95% were excluded from the study.
African ancestry estimation
Given that the genetic pool of African Americans is mainly a
result of admixture between western African and European
populations [18], with limited Native American/Asian genetic
influences [36,37], individual ancestries for all subjects combined
were modeled using two ancestral populations (West African and
European) by means of STRUCTURE [38]. For ancestry
estimation in REACH and BASS, data for 95 AIMs (all but
rs6894171) from 60 European and 131 West African samples from
our previous studies were used as reference [26]. For ancestry
estimation in CHIRAH, data for all 66 AIMs from the HapMap II
from 60 unrelated Yoruba Nigerians (YRI) and 60 unrelated Utah
residents with ancestry from northern and western Europe (CEU)
were used as reference [39]. STRUCTURE was employed under
the admixture model using prior population information and
independent allele frequencies. The number of parental popula-
tions ranged from K=1 to K=3 with a burn-in length of 50,000
for 70,000 repetitions. The results showed that the model with best
likelihood was K=2 ancestral populations. For comparison,
individual proportions of European and African ancestries were
also estimated using ADMIXMAP [40], with 2,000 burn-in and
10,000 iterations, using allele frequencies from parental popula-
tions as priors. The diagnosis test for the model (i.e. the test of
dispersion) performed by ADMIXMAP program indicated a good
fit of the data to the two-parental population admixture model
(Bayesian p-values.0.35). Pearson and Spearman’s rank correla-
tions were used to compare estimates derived from STRUCTURE
and ADMIXMAP.
Statistical analysis
Independent t-tests with equal variances not assumed were
initially used to compare the individual ancestry estimates between
REACH and BASS asthmatics and controls. We next used
multiple logistic regression models to test the association between
individual ancestry and asthma, adjusting for relevant covariates
using SPSS 19 (SPSS Inc., Chicago, IL). Individual associations of
AIMs with asthma were tested by means of the Cochran-Armitage
trend test under an additive model and p-values obtained by 1,000
permutations by means of a custom script [26]. Logistic regression
models were also used to test the association of individual AIMs
with asthma, adjusting for the African ancestry estimates.
For the statistical analysis of longitudinal exacerbations in the
CHIRAH cohort, exacerbation data (at 3 month intervals up to six
times for the number of exacerbations over the preceding 3 months)
were modeled as a Poisson regression. All available measurements
were included in the analysis using Generalized Estimating
Equations (GEE) modeling with robust standard errors, in order
to adjust for repeated measures within individuals. For that, the
compound symmetry correlation structure was used, assuming that
the correlation between a subject’s observations was equal across
time points. Since GEE adjusted for the co-variances and variances
inourmodel, any over-dispersion (wherethe mean and the variance
were not equal) was also adjusted. The GEE model was fitted using
PROC GENMOD in SAS 9.1 (SAS Institute Inc., Cary, NC), with
a Poisson distribution and link function of log. In order to determine
which covariates to include in the models, we initially included basic
demographic covariates, measures of socioeconomic status (SES),
including annual household income and insurance status, and well
established factors associated with exacerbation, in particular:
environmental tobacco exposure, use of inhaled corticosteroids, and
baseline forced expiratory volume in one second (FEV1). All other
potential confounders were included only if associated with the
outcome of exacerbation on univariate analysis (p-value,0.2).
These included the duration of asthma, and asthma severity at
baseline (based on the GINA 2002 guidelines algorithm). To test the
association between individual ancestry and longitudinal exacerba-
tions, covariates included in the final model were: age, gender,
follow-up time, annual household income (categorized as below or
above $30,000/year), insurance status (private/non-private), sever-
ity at baseline, as determined by application of GINA 2002
guidelines algorithm, baseline FEV1, and time varying variables
(including smoking status and use of inhaled corticosteroids at each
visit). The same model was used for the association of individual
AIMs with longitudinal exacerbations, both with and without the
African ancestry estimates as a covariate.
In order to judge the significant individual association of AIMs
in the context of the multiple comparisons performed, a False
African Ancestry and Asthma Risk
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value of 0.05 was established to declare significance, in order to
limit the expected proportion of false positives incurred in the
study when a particular individual AIM association test was called
significant.
Results
We excluded samples from individuals self-reporting an ancestry
other than African American (5 controls and 12 cases) or with
.5% of genotypes missing (37 controls and 25 cases). Thus, the
final sample size used for the study consisted on a total of 439
controls and 357 cases (146 controls and 183 cases from REACH
study, 293 controls and 174 cases from BASS study) to test the
association of African ancestry with asthma susceptibility (see
Table S3 for sample characteristics), and 321 cases from CHIRAH
study to test the association of African ancestry with asthma
exacerbations.
Mean (6SD) African estimates obtained overall case-control
samples using STRUCTURE and ADMIXMAP were
79.8616.5% and 81.5615.6%, respectively. For REACH,
STRUCTURE and ADMIXMAP estimates overall samples were
81.5615.5% and 83.2614.3%, respectively. For BASS, STRUC-
TURE and ADMIXMAP estimates overall samples were
78.5617.1% and 80.3614.3%, respectively. For the CHIRAH
samples, STRUCTURE and ADMIXMAP estimates were
79.7611.7% and 81.669.7%, respectively. Given that individual
African estimates obtained by STRUCTURE and ADMIXMAP
were highly correlated across all three studies (Pearson
corr.=0.98, p,1.0E-5; Spearman’s rho=0.94, p,1.0E-5), in
the following we refer only to STRUCTURE estimates.
Mean African ancestry was significantly (p,0.0001) greater in
asthmatics (82.0614.0%) than in non-asthmatics (77.8618.1%),
with a consistent direction of the effect across the two samples
albeit to a minor extent in the community-based study (83.9% vs.
78.3%, p=0.001 for REACH; 80.0% vs. 77.6%, p=0.126 for
BASS) (Table 1). The differences between cases and controls were
also evident from the distribution of African ancestry proportions
by sample group, as represented in Figure 1. To formally test the
association of African ancestry with asthma susceptibility, we
utilized logistic regression adjusting for age, gender and the study
site, and the results again supported a strong association of African
ancestry with the risk of asthma (odds ratio [OR]: 4.55; 95%
Confidence Interval [CI]: 1.69–12.29; p=0.003) (Table 2). This
translated into an OR of 1.16 (95% CI: 1.06–1.28, p=0.002) for
the risk of asthma per 10% increase in African ancestry, after
adjusting for age, gender and the study site. However, African
ancestry did not show a statistically significant association with
asthma exacerbations (p=0.965) based on the model of longitu-
dinal data collected for African Americans from the CHIRAH
study (exacerbations over the preceding 3 months, 3 month
intervals, up to six intervals) (Table 3). Similar results were
obtained both for asthma and asthma exacerbations when
ADMIXMAP estimates were used in the model (not shown).
We might have left unexplained a fraction of individual
ancestries assignable to genetic influences from non-African and
non-European populations. To test such possibility, we finally
analyzed whether ancestry adjustments diminished potentially
significant associations between individual AIMs and asthma
susceptibility and exacerbations, assuming that they should be due
to chance or to the effects of residual population stratification
existing in the sample. We first determined whether specific AIMs
used for ancestry estimation were associated individually with
asthma susceptibility (for simplicity, this was done only for the
overall case-control sample) or exacerbations. In case-control
samples, twenty-two AIMs were nominally associated in univariate
association tests (Table S1). However, after adjusting for relevant
covariates, including African ancestry, only four AIMs remained
nominally associated, although none of them was considered
significant given the number of comparisons performed (lowest
p=0.029; lowest q=0.571). Similar results were obtained when
testing for individual AIM association with asthma exacerbations
in CHIRAH. Five AIMs showed nominal association when
ancestry was not considered, and four AIMs remained nominally
associated when ancestry was considered in the models, although
none of them was considered significant given the number of
comparisons performed (lowest p=0.010; lowest q=0.380) (Table
S2). Taken together, these results suggest that the adjustment for
the ancestry estimates removed the majority of population
stratification present in the samples, and that associations of
individual AIMs with asthma susceptibility and exacerbations
likely represent false positives due to chance. Thus, a two-
population admixture model allowed adequately estimating
individual ancestries in these African American samples.
Discussion
Several evidences suggest that genetic risk factors for asthma
might differ among populations [6,7,11,13,42]. However, few
studies have focused on the genetic basis of asthma among ethnic
minorities such as African Americans, a population with a
particularly high incidence of asthma and severe disease. Here we
investigated whether genetic ancestry, as estimated from several
dozen genetic markers extremely informative for ancestry, was
associated with risk of asthma or asthma exacerbations in a total of
1,117 African Americans. We demonstrated that African genetic
ancestry associates with asthma risk. This association was not due to
potential confounders such as age and gender. In fact, the effect was
consistent across the two case-control samples, although statistical
significance was not reached for the BASS study. However,
confounding effects attributable to other relevant environmental,
early life or SES factors, among others, cannot be ruled out. While
type I error, biological mechanisms (e.g. due to gene-environment
interactions) and/or selection bias may possibly explain the very
Table 1. Differences in African ancestry estimates (%, mean6SD) among case-control samples.
Sample Asthmatics Non-asthmatics Difference (95% CI)
a p-value
b
Case-control (Ca=357/Co=439) 82.0614.0 77.8618.1 4.2 (2.0-6.4) ,0.0001
REACH (Ca=183/Co=146) 83.9611.6 78.3618.8 5.6 (2.2–8.9) 0.001
BASS (Ca=174/Co=293) 80.0615.9 77.6617.7 2.4 (0.0–5.6) 0.126
aMean difference between asthmatics and non-asthmatics.
bt-test. Sample sizes in parenthesis.
doi:10.1371/journal.pone.0026807.t001
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samples, we favored the latter possibility by incurring in a spectrum
of disease bias [43]. Note that all REACH cases were selected for an
‘‘extreme’’ and severe phenotype (as they were recruited from the
ED of the Hospital), while recruitment in BASS was community-
based, which therefore is expected to have included cases from a
broader spectrum of the disease phenotype.
Importantly, our study expands previous observations made for
other African-descent populations. Firstly, we replicate the
association of African ancestry and risk of asthma in independent
African-admixed populations different from those studied previous-
ly [21,22]. Secondly, for the first time, we ascertained the potential
effects of African ancestry in asthma exacerbations based on
prospective, longitudinal determination of exacerbation pheno-
types. In this respect, we admit that this study had limited power to
detect modest effects of ancestry in asthma exacerbations (20% for
an OR in the 1.20–1.50 range), and that further studies with larger
sample sizes will be needed for a better assessment of the risk.
Individuals with self-reported African American descent from the
studied locations exhibit ,80% African ancestry, consistent with
previous studies utilizing from .3,000 markers with information for
African and European ancestries [20,22,44,45] to 500,000 markers
from the genome [19], ensuring that these were properly estimated.
Additionally, we used independent sets of 66 and 96 AIMs allowing
us to precisely estimate individual ancestral proportions to major
continental populations (e.g. the median size of the 90% Bayesian
confidence interval overall REACH individuals was 17.0%; P25–
P75: 14.6–18.5%) [33,46]. Thus, along with the diagnostic results
from the two alternative programs used for the admixture model, as
well as by judging the limited residual association of individual
AIMs after adjustingfor the admixture estimates, these data support
the precision of the estimated ancestries.
For a case-control study with unrelated individuals, the best
source of controls is the population from which cases were
ascertained, and recruiting admixed subjects from the same clinic
or very nearby geographic location can even minimize differences
in the degree of admixture [22]. In the present study, despite
obtaining African American case-control samples from individuals
residing in similar (urban) areas, and that we were able to find
similar effects for the ancestry in asthma risk in two independent
case-control samples, we cannot exclude the fact that residual
confounding may exist due to unmeasured factors (environmental,
social, cultural, or behavioral). In addition, albeit sampling did not
include close relative subjects, cryptic relatedness cannot be ruled
out from the study. However, simulation studies have evidenced
the limited impact of including subjects with close familiar
relationships in population-based association studies [47]. Most
importantly, we did not have data for the location of residence (as
a proxy for exposure to pollution) and SES. Previous studies have
not observed African ancestries in African Americans varying with
urban or suburban residence [48]. However, it is well known that
SES is strongly correlated with race and ethnic background and is
a robust predictor of access to and quality of health care and
education in the U.S., which, in turn, may be associated with
differences in the incidence and outcomes of those diseases [17].
By focusing exclusively on African Americans, we may not totally
alleviate this confounding given that skin pigmentation and
African ancestry are modestly correlated in African Americans
[49]. Earlier studies have suggested that biological endpoints, such
as blood pressure, might be influenced by skin color and
hypothesized that this was due to SES [50–53]. However, a more
recent evaluation did not reveal any correlation linking skin
pigmentation with health outcomes among African Americans
[54]. This makes a residual correlation of individual admixture
Figure 1. Histograms representing the proportion of individual
African ancestry estimates based on 95 AIMs for REACH (A),
BASS (B), and overall case-controls (C).
doi:10.1371/journal.pone.0026807.g001
Table 2. Association of African ancestry and asthma using
logistic regression models.
a
Sample Odds ratio 95% CI p-value
Case-control 4.55 1.69–12.29 0.003
REACH 10.10 2.12–48.21 0.004
BASS 2.62 0.77–8.93 0.125
aMultiple logistic regression models included age, gender and the study site.
The African ancestry was introduced as a proportion in the range 0–1.
doi:10.1371/journal.pone.0026807.t002
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support of this, previous studies exploring the relationship between
African ancestry and asthma risk, asthma-related traits or allergic
sensitization, did not observe confounding effects due to SES
[21,22,48].
In summary, a consistent association of African ancestry with
asthma risk was observed in a large case-control sample of self-
reported African American subjects. Although confounding effects
attributable to other relevant risk factors cannot be ruled out, we
replicate previous findings and support the notion that ethnic
disparities in asthma incidence are affected, in part, by genetic
determinants. Frequency differences for risk alleles across
populations and/or differential gene-environmental interactions
may lead to differential disease susceptibility.
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